Skip to main content
Oxford University Hospitals NHS Foundation Trust
Oxford Critical Care

Coronavirus / COVID-19

If you have a new continuous cough and/or high temperaturedo not come to our hospitals.

Follow the national advice and stay at home for seven days. For most people, coronavirus (COVID-19) will be a mild infection, but for some of our patients it is a higher risk. Please help us to help you.

Important information about non-urgent inpatient operations and outpatient appointments.

From Monday 23 March we will not allow any visitors to our hospitals – with a few exceptions.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.


Mark Borthwick

Mark Borthwick

Mark joined the Trust in 2001, becoming a consultant pharmacist in 2007.

He has a number of clinical interests, the most widely recognised of which is in the management of delirium, although he continues to publish studies in other areas such as stress ulcer prophylaxis, medication infusion practice and on the role and impact of critical care pharmacists.

Some of this work informs GPICS standards, where he is an author of the Pharmacy section.

In 2009/10 Mark co-authored award winning guidelines on the management of flu to deal with the emergent threat of swine flu, and is an author of the Public Health England flu guidelines.

Mark is a founding fellow of the Royal Pharmaceutical Society's Faculty and is also a member of the Royal Pharmaceutical Society's Hospital Expert Advisory Group. He is Co-Chair of the UK Clinical Pharmacy Association, and is the external examiner for the Postgraduate Diploma in General Pharmacy Practice and MSc in Advanced Pharmacy Practice for University College London.